Literature DB >> 21556379

The clinical and histologic efficacy of xenograft granules for maxillary sinus floor augmentation.

Myron Nevins1, Marcelo Camelo, Nicola De Angelis, James J Hanratty, Wahn G Khang, Jong-Jin Kwon, Giulio Rasperini, Isabella Rocchietta, Peter Schupbach, David M Kim.   

Abstract

The objective of this study was to investigate the potential of xenograft (cancellous bovine bone) granules to form vital bone in non-natural bone-forming areas of maxillary sinuses. Fourteen sinus augmentations were performed in 14 patients. Surgical outcomes were uneventful, and sufficient radiopaque volume was present radiographically to place dental implants in all sites. Clinical reentry at 6 months revealed bone formation at the osteotomy site. Histologic evaluation of the obtained bone cores revealed that xenograft granules were integrated and surrounded by woven bone and lamellar bone that were in close contact with the particles. The average percentage of newly formed bone at 6 months was 27.5% ± 8.9%. Vital bone formation using the xenograft granules was supported by both clinical and histologic evidence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556379

Source DB:  PubMed          Journal:  Int J Periodontics Restorative Dent        ISSN: 0198-7569            Impact factor:   1.840


  2 in total

1.  Comparison of Two Xenograft Materials Used in Sinus Lift Procedures: Material Characterization and In Vivo Behavior.

Authors:  María Piedad Ramírez Fernández; Patricia Mazón; Sergio A Gehrke; Jose Luis Calvo-Guirado; Piedad N De Aza
Journal:  Materials (Basel)       Date:  2017-06-07       Impact factor: 3.623

2.  Histological and Histomorphometric Evaluation of New Bone Formation after Maxillary Sinus Augmentation with Two Different Osteoconductive Materials: A Randomized, Parallel, Double-Blind Clinical Trial.

Authors:  Giuseppe Grasso; Stefano Mummolo; Sara Bernardi; Davide Pietropaoli; Giuseppe D'Ambrosio; Giovanna Iezzi; Adriano Piattelli; Serena Bianchi; Enrico Marchetti
Journal:  Materials (Basel)       Date:  2020-12-03       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.